| CAS ID: | 142340-99-6 |
| Molecular Formula: | C20H32N5O8P |
| Molecular Weight: | 501.5 g/mol |
| Monoisotopic Mass: | 501.1988 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | GS-0840 | Adefovir dipivoxil | HEPSERA |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23) | See All |
| InChI Key: | WOZSCQDILHKSGG-UHFFFAOYSA-N | |
| Smiles: | CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc12)OCOC(=O)C(C)(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00347009 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | July 4, 2006 | Last Verified | June 4, 2012 |
| Sponsor | GlaxoSmithKline | ||
Trial Record 2
| ClinicalTrial ID | NCT02327689 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | December 30, 2014 | Last Verified | December 30, 2014 |
| Sponsor | Asian-Pacific Alliance of Liver Disease, Beijing | ||
Trial Record 3
| ClinicalTrial ID | NCT01718587 | Disease | Liver fibrosis |
| Phase | Phase 1,Phase 2 | Status | Unknown |
| First Received | October 31, 2012 | Last Verified | October 31, 2012 |
| Sponsor | General Hospital of Chinese Armed Police Forces | ||
Trial Record 4
| ClinicalTrial ID | NCT01720238 | Disease | Liver fibrosis |
| Phase | Status | Unknown | |
| First Received | November 2, 2012 | Last Verified | July 28, 2015 |
| Sponsor | Beijing Friendship Hospital | ||